Clinical Study
Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR
Figure 1
Pioglitazone decreased plasma proinflammatory factors concentrations in patients after coronary DES implantation. The results are presented as raw data. Compared to the control group, PIO significantly reduced plasma IL-6, TNF-, and MMP-9 concentrations by TWRMANOVA (, 0.008, 0.002, and 0.012, resp.). compared with baseline.
(a) |
(b) |
(c) |